- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/00 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patent holdings for IPC class C07D 233/00
Total number of patents in this class: 133
10-year publication summary
|
8
|
3
|
4
|
4
|
2
|
2
|
2
|
3
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Arkema France | 4189 |
5 |
| Novartis AG | 10341 |
4 |
| Bristol-myers Squibb Company | 4815 |
4 |
| Merck Sharp & Dohme Corp. | 2184 |
2 |
| Boehringer Ingelheim International GmbH | 4496 |
2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 60 |
2 |
| Allergan, Inc. | 2204 |
2 |
| Takeda Pharmaceutical Company Limited | 2716 |
2 |
| Antecip Bioventures II LLC | 362 |
2 |
| Kyushu University, National University Corporation | 1694 |
2 |
| PGI Drug Discovery LLC | 32 |
2 |
| Sumitomo Riko Company Limited | 1124 |
2 |
| Sunovion Pharmaceuticals Inc. | 247 |
2 |
| (chan-n) Changzhou Green Photosensitive Materials Co., Ltd. | 6 |
2 |
| F. Hoffmann-La Roche AG | 7841 |
1 |
| 3m Innovative Properties Company | 17507 |
1 |
| BASF SE | 21151 |
1 |
| Janssen Pharmaceutica N.V. | 3226 |
1 |
| Centre National de La Recherche Scientifique | 10895 |
1 |
| Bayer MaterialScience AG | 730 |
1 |
| Other owners | 92 |